Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TalkMed Group's share price for the quarter that ended in Dec. 2024 was S$0.445. TalkMed Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 1,329.14 Mil. Therefore, TalkMed Group's market cap for the quarter that ended in Dec. 2024 was S$591.47 Mil.
TalkMed Group's quarterly market cap
increased
from Dec. 2023 (S$503.70 Mil) to Jun. 2024 (S$524.03 Mil) and
increased
from Jun. 2024 (S$524.03 Mil) to Dec. 2024 (S$591.47 Mil).
TalkMed Group's annual market cap
declined
from Dec. 2022 (S$529.02 Mil) to Dec. 2023 (S$503.70 Mil) but then
increased
from Dec. 2023 (S$503.70 Mil) to Dec. 2024 (S$591.47 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TalkMed Group's Enterprise Value for Today is S$510.40 Mil.
TalkMed Group Market Cap Historical Data
The historical data trend for TalkMed Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TalkMed Group's Market Cap
For the Medical Care Facilities subindustry, TalkMed Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TalkMed Group's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's Market Cap distribution charts can be found below:
* The bar in red indicates where TalkMed Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TalkMed Group's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TalkMed Group (SGX:5G3) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TalkMed Group Market Cap Related Terms
Thank you for viewing the detailed overview of TalkMed Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:5G3 has been successfully added to your 